Literature DB >> 10612071

Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle.

D R Sinacore1, N C Withrington.   

Abstract

STUDY
DESIGN: Review of selected literature describing the outcomes related to the management of acute Charcot foot arthropathies in patients with diabetes mellitus.
OBJECTIVE: To familiarize the rehabilitation specialist with the general principles of nonsurgical management for patients with acute neuropathic arthropathies of the foot and ankle.
BACKGROUND: Neuropathic (Charcot) arthropathy of the foot or ankle is the most destructive and disabling chronic complication of all diabetic foot disease. METHODS AND MEASURES: We discuss the clinical presentation and the role that orthopaedic and sports physical therapists may have in identifying and preventing complications and the long-term disability associated with these arthropathies. We summarize the outcomes of 15 published reports from 1985-1999 located using the MEDLINE database from 1966-present. Studies were selected and included if the authors reported on (1) 2 or more patients with diabetes mellitus and acute Charcot arthropathies; (2) the short-term or long-term outcomes, including the length of follow-up; and (3) the pattern or location of the arthropathy. The short-term outcomes (percentage of patients healed, average time to healing) and long-term outcomes (percentage in whom treatment failed, amputation, disability) after treatment by immobilization alone or immobilization after surgery were reviewed and summarized.
RESULTS: The prognosis for an individual with severe neuropathic skeletal foot deformities is poor. Eleven deaths (3.65%) in 301 patients were reported within the average follow-up period of 2.5 years after treatment for Charcot arthropathy. Partial or complete foot amputation occurred in 20 (6.6%) of 301, whereas 83 (28%) of 301 patients reviewed had mobility limitations or required ankle-foot orthoses or permanent bracing or assistive devices for ambulation at the time of follow-up.
CONCLUSION: Rehabilitation specialists can improve the short-term outcomes and limit the long-term disabilities in patients with diabetes mellitus and peripheral neuropathy. Early recognition and prompt immobilization are the basic principles of nonsurgical management that influence therapeutic outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10612071     DOI: 10.2519/jospt.1999.29.12.736

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  16 in total

1.  Role of dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus.

Authors:  Virna Zampa; Irene Bargellini; Loredana Rizzo; Francesca Turini; Simona Ortori; Alberto Piaggesi; Carlo Bartolozzi
Journal:  Skeletal Radiol       Date:  2011-01-28       Impact factor: 2.199

Review 2.  Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

Authors:  William J Jeffcoate
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

3.  Proton magnetic resonance spectroscopy in the evaluation of patients with acute Charcot neuro-osteoarthropathy.

Authors:  Francesca Bolacchi; Luigi Uccioli; Salvatore Masala; Laura Giurato; Valeria Ruotolo; Marco Meloni; Eleonora Baffari; Elenia Cinelli; Marcello Cadioli; Ettore Squillaci; Giovanni Simonetti; Alberto Bergamini
Journal:  Eur Radiol       Date:  2013-06-11       Impact factor: 5.315

4.  Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot.

Authors:  David R Sinacore; Mary K Hastings; Kathryn L Bohnert; Faye A Fielder; Dennis T Villareal; Vilray P Blair; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2008-09-18

5.  Immobilization-induced osteolysis and recovery in neuropathic foot impairments.

Authors:  David R Sinacore; Mary K Hastings; Kathryn L Bohnert; Michael J Strube; David J Gutekunst; Jeffrey E Johnson
Journal:  Bone       Date:  2017-09-20       Impact factor: 4.398

6.  Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy.

Authors:  Mary K Hastings; David R Sinacore; Faye A Fielder; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2005-03

7.  Progression of foot deformity in Charcot neuropathic osteoarthropathy.

Authors:  Mary K Hastings; Jeffrey E Johnson; Michael J Strube; Charles F Hildebolt; Kathryn L Bohnert; Fred W Prior; David R Sinacore
Journal:  J Bone Joint Surg Am       Date:  2013-07-03       Impact factor: 5.284

8.  A case of diabetic Charcot arthropathy of the foot and ankle.

Authors:  John M Embil; Elly Trepman
Journal:  Nat Rev Endocrinol       Date:  2009-10       Impact factor: 43.330

9.  Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9.

Authors:  Voraluck Phatarakijnirund; Steven Mumm; William H McAlister; Deborah V Novack; Deborah Wenkert; Karen L Clements; Michael P Whyte
Journal:  Bone       Date:  2015-12-31       Impact factor: 4.398

10.  Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.

Authors:  Min-Woong Sohn; Rodney M Stuck; Michael Pinzur; Todd A Lee; Elly Budiman-Mak
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.